Markers of Cardiac Autonomic Function During Consecutive Day Peak Exercise Tests in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. — CFSMEATLAS
Markers of Cardiac Autonomic Function During Consecutive Day Peak Exercise Tests in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Nelson, Maximillian J, Buckley, Jonathan D, Thomson, Rebecca L et al. · Frontiers in physiology · 2021 · DOI
Quick Summary
This study looked at how the hearts of ME/CFS patients respond to exercise on two consecutive days, comparing them to healthy people. Researchers measured heart rate patterns and recovery after exercise, finding that ME/CFS patients had slower heart rate recovery after working out. However, these measurements alone were not reliable enough to diagnose ME/CFS, suggesting that a single heart rate test may not be a useful diagnostic tool on its own.
Why It Matters
Identifying non-maximal exercise markers could help diagnose ME/CFS without requiring patients to undergo exhausting maximal exercise tests that trigger post-exertional malaise. Understanding how cardiac autonomic function changes across consecutive days may shed light on why many ME/CFS patients experience worsening symptoms after physical activity. This research contributes to the growing evidence that ME/CFS involves measurable physiological abnormalities in the nervous system's control of heart function.
Heart rate at ventilatory threshold was higher on Day Two compared to Day One testing.
Heart rate variability patterns (low frequency to high frequency power ratio) were higher during the sub-maximal warm-up on Day Two.
Receiver operating characteristic analysis for heart rate recovery achieved 74.8% area under the curve on Day One testing.
The sensitivity and specificity of heart rate recovery measurements were too low (63% and 40% respectively) for clinical diagnostic use.
Inferred Conclusions
Impaired heart rate recovery is present in ME/CFS patients and distinguishes them from healthy controls, suggesting cardiac autonomic dysfunction.
Repeated exercise on consecutive days produces measurable changes in heart rate parameters in both groups, indicating a time effect.
While heart rate recovery shows promise as a physiological marker of ME/CFS, it lacks sufficient diagnostic accuracy when used alone.
Sub-maximal assessments of cardiac autonomic function may offer safer alternatives to maximal exercise testing in ME/CFS populations.
Remaining Questions
Can combining multiple heart rate parameters (rather than HRR alone) improve sensitivity and specificity for ME/CFS diagnosis?
What This Study Does Not Prove
This study does not establish heart rate recovery as a reliable standalone diagnostic test for ME/CFS due to low sensitivity and specificity. The cross-sectional design cannot determine whether altered heart rate patterns cause post-exertional malaise or are simply correlated with it. The small sample size (16 ME/CFS patients) limits generalizability of findings to the broader ME/CFS population.
Do these cardiac autonomic changes directly relate to post-exertional malaise severity, and can they predict which patients will experience symptom exacerbation?
How do these findings extend to larger, more diverse ME/CFS populations, and do they vary by disease severity or symptom profile?
Could longitudinal studies tracking these heart rate parameters over time reveal whether they are stable biomarkers or change with disease progression?